Higher prevalence of autoantibodies to insulin and GAD65 in Swedish compared to Lithuanian children with type 1 diabetes

Diabetes Research and Clinical Practice

Volumn 72, Issue 3, 2006, Pages 308-314

  Holmberg, Hanna ^a   Vaarala, Outi ^a,b   Sadauskaite Kuehne, Vaiva ^c   Ilonen, Jorma ^d   Padaiga, Žilvinas ^c   Ludvigsson, Johnny ^a  

^a Clinical Research Center   (Sweden)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

^d UNIVERSITY OF TURKU   (Finland)

Author keywords

Beta cell autoantibodies; HLA risk genotype; Lithuania; Sweden; Type 1 diabetes

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUTAMATE DECARBOXYLASE 65; HEMOGLOBIN A1C; INSULIN; INSULIN ANTIBODY; KETONE; PHOSPHOTYROSINE;

ADOLESCENT; ARTICLE; CELLULAR IMMUNITY; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HAPLOTYPE; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LITHUANIA; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET BETA CELL; PREVALENCE; SEX DIFFERENCE; SWEDEN;

ADOLESCENT; AUTOANTIBODIES; AUTOIMMUNITY; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTAMATE DECARBOXYLASE; HAPLOTYPES; HEMOGLOBIN A, GLYCOSYLATED; HLA-DQ ANTIGENS; HLA-DR3 ANTIGEN; HLA-DR4 ANTIGEN; HUMANS; INFANT; INSULIN; INSULIN ANTIBODIES; INSULIN-SECRETING CELLS; ISOENZYMES; LITHUANIA; MALE; POLYMORPHISM, GENETIC; SWEDEN;

EID: 33646725466     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2005.10.022     Document Type: Article

References (36)

1. Castano L., and Eisenbarth G.S. Type 1 diabetes: a chronic disease of human, mouse and rat. Annu. Rev. Immunol. 8 (1990) 647-679
2. Todd J.A., Bell J.I., and McDevitt H.O. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329 (1987) 599-604
3. Thorsby E., and Ronningen K.S. Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36 (1993) 371-377
4. Horn G.T., Bugawan T.L., Long C.M., and Erlich H.A. Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 6012-6016
5. She J.X. Susceptibility to type I diabetes: HLA-DQ and DR revisited. Immunol. Today 17 (1996) 323-329
6. Hermann R., Turpeinen H., Laine A.P., Veijola R., Knip M., Simell O., et al. HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families. Tissue Antigens 62 (2003) 162-169
7. Bennett S.T., Lucassen A.M., Gough S.C., Powell E.E., Undlien D.E., Pritchard L.E., et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat. Genet. 9 (1995) 284-292
8. Bell G.I., Horita S., and Karam J.H. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes 33 (1984) 176-183
9. Ronningen K.S., Keiding N., and Green A. Correlations between the incidence of childhood-onset type I diabetes in Europe and HLA genotypes. Diabetologia 44 Suppl. 3 (2001) B51-B59
10. Nejentsev S., Koskinen S., Sjoroos M., Reijonen H., Schwartz E.I., Kovalchuk L., et al. Distribution of insulin-dependent diabetes mellitus (IDDM)-related HLA alleles correlates with the difference in IDDM incidence in four populations of the Eastern Baltic region. Tissue Antigens 52 (1998) 473-477
11. Onkamo P., Vaananen S., Karvonen M., and Tuomilehto J. Worldwide increase in incidence of type I diabetes-the analysis of the data on published incidence trends. Diabetologia 42 (1999) 1395-1403
12. Bingley P.J., Christie M.R., Bonifacio E., Bonfanti R., Shattock M., Fonte M.-T., et al. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody positive relatives. Diabetes 43 (1994) 1304-1310
13. Verge C.F., Stenger D., Bonifacio E., Coleman P.G., Pilcher C., Bingley P.J., et al. Combined use of autoantibodies (IA-2ab, GADab, IAA, ICA) in type I diabetes: combinatorial islet autoantibody workshop. Diabetes 47 (1998) 1857-1866
14. Kimpimaki T., Kulmala P., Savola K., Kupila A., Korhonen S., Simell T., et al. Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population. J. Clin. Endocrinol. Metab. 87 (2002) 4572-4579
15. Green A., Patterson C.C., and on behalf of the EURODIAB TIGER study group. Trends in the incidence of childhood-onset diabetes in Europe 1989-1998. Diabetologia 44 Suppl. 3 (2001) B3-B8
16. Adojaan B., Knip M., Vahasalo P., Karjalainen J., Kalits I., and Akerblom H.K. Relationship between the incidence of childhood IDDM and the frequency of ICA positivity in nondiabetic children in the general population. Diabetes Care 19 (1996) 1452-1454
17. Marciulionyte D., Williams A.J.K., Bingley P.J., Urbonaite B., and Gale E.A.M. A comparison of the prevalence of islet autoantibodies in children from two countries with differing incidence of diabetes. Diabetologia 44 (2001) 16-21
18. Kondrashova A., Reunanen A., Romanov A., Karvonen A., Viskari H., Vesikari T., et al. A six-fold gradient in the incidence of type 1 diabetes at the eastern border of Finland. Ann. Med. 37 (2005) 67-72
19. Sadauskaite-Kuehne V., Ludvigsson J., Padaiga Z., Jasinskiene E., and Samuelsson U. Longer breastfeeding is an independent protective factor against development of type 1 diabetes mellitus in childhood, Diabetes. Metab. Res. Rev. 20 (2004) 150-157
20. Sadauskaite-Kuehne V., Samuelsson U., Jasinskiene E., Padaiga Z., Urbonaite B., Edenvall H., et al. Severity at onset of childhood type 1 diabetes in countries with high and low incidence of the condition. Diabetes Res. Clin. Pract. 55 (2002) 247-254
21. Vardi P., Ziegler A.G., Mathews J.H., Dib S., Keller R.J., Ricker A.T., et al. Concentration of insulin autoantibodies at onset of type I diabetes. Inverse log-linear correlation with age. Diabetes Care 11 (1988) 736-739
22. Verge C.F., Howard N.J., Rowley M.J., Mackay I.R., Zimmet P.Z., Egan M., et al. Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study. Diabetologia 37 (1994) 1113-1120
23. Williams A.J.K., Bingley P.J., Bonifacio E., Palmer J.P., and Gale E.A.M. A novel micro-assay for insulin autoantibodies. J. Autoimmun. 10 (1997) 473-478
24. Sjoroos M., Iitia A., Ilonen J., Reijonen H., and Lovgren T. Triple-label hybridization assay for type-1 diabetes-related HLA alleles. Biotechniques 18 (1995) 870-877
25. Nejentsev S., Sjoroos M., Soukka T., Knip M., Simell O., Lovgren T., et al. Population-based genetic screening for the estimation of type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci. Diabet. Med. 16 (1999) 985-992
26. Laine A.P., Nejentsev S., Veijola R., Korpinen E., Sjoroos M., Simell O., et al. A linkage study of 12 IDDM susceptibility loci in the Finnish population. Diabetes Metab. Res. Rev. 20 (2004) 144-149
27. Haller K., Kisand K., Nemvalts V., Laine A.P., Ilonen J., and Uibo R. Type 1 diabetes is insulin -2221 MspI and CTLA-4 +49 A/G polymorphism dependent. Eur. J. Clin. Invest. 34 (2004) 543-548
28. Karjalainen J., Knip M., Mustonen A., Ilonen J., and Akerblom H.K. Relation between insulin antibody and complement-fixing islet cell antibody at clinical diagnosis of IDDM. Diabetes 35 (1986) 620-622
29. Arslanian S.A., Becker D.J., Rabin B., Atchison R., Eberhardt M., Cavender D., et al. Correlates of insulin antibodies in newly diagnosed children with insulin-dependent diabetes before insulin therapy. Diabetes 34 (1985) 926-930
30. Pundziute-Lycka A., Dahlquist G., Nystrom L., Arnqvist H., Bjork E., Blohme G., et al. The incidence of Type I diabetes has not increased but shifted to a younger age at diagnosis in the 0-34 years group in Sweden 1983-1998. Diabetologia 45 (2002) 783-791
31. Samuelsson U., Sadauskaite-Kuehne V., Padaiga Z., Ludvigsson J., and for the DEBS study group. A fourfold difference in the incidence of type 1 diabetes between Sweden and Lithuania but similar prevalence of autoimmunity. Diabetes Res. Clin. Pract. 66 (2004) 173-181
32. Sabbah E., Savola K., Kulmala P., Veijola R., Vahasalo P., Karjalainen J., et al. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes in Finland Study Group. J. Clin. Endocrinol. Metab. 84 (1999) 1534-1539
33. Komulainen J., Knip M., Lounamaa R., Vahasalo P., Karjalainen J., Sabbah E., et al. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group. Diabet. Med. 14 (1997) 532-537
34. Walter M., Albert E., Conrad M., Keller E., Hummel M., Ferber K., et al. IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of type 1 diabetes and associated autoimmunity. Diabetologia 46 (2003) 712-720
35. Sarugeri E., Dozio N., Belloni C., Meschi F., Pastore M.R., and Bonifacio E. Autoimmune responses to the beta cell autoantigen, insulin, and the INS VNTR-IDDM2 locus. Clin. Exp. Immunol. 114 (1998) 370-376
36. Perez De Nanclares G., Bilbao J.R., Calvo B., Vitoria J.C., Vazquez F., and Castano L. 5′-Insulin gene VNTR polymorphism is specific for type 1 diabetes: no association with celiac or Addison's disease. Ann. N. Y. Acad. Sci. 1005 (2003) 319-323